240 related articles for article (PubMed ID: 23185384)
1. RIN3 is a negative regulator of mast cell responses to SCF.
Janson C; Kasahara N; Prendergast GC; Colicelli J
PLoS One; 2012; 7(11):e49615. PubMed ID: 23185384
[TBL] [Abstract][Full Text] [Related]
2. RabGEF1 regulates stem cell factor/c-Kit-mediated signaling events and biological responses in mast cells.
Kalesnikoff J; Rios EJ; Chen CC; Nakae S; Zabel BA; Butcher EC; Tsai M; Tam SY; Galli SJ
Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2659-64. PubMed ID: 16533754
[TBL] [Abstract][Full Text] [Related]
3. Characterization of RIN3 as a guanine nucleotide exchange factor for the Rab5 subfamily GTPase Rab31.
Kajiho H; Sakurai K; Minoda T; Yoshikawa M; Nakagawa S; Fukushima S; Kontani K; Katada T
J Biol Chem; 2011 Jul; 286(27):24364-73. PubMed ID: 21586568
[TBL] [Abstract][Full Text] [Related]
4. RIN3: a novel Rab5 GEF interacting with amphiphysin II involved in the early endocytic pathway.
Kajiho H; Saito K; Tsujita K; Kontani K; Araki Y; Kurosu H; Katada T
J Cell Sci; 2003 Oct; 116(Pt 20):4159-68. PubMed ID: 12972505
[TBL] [Abstract][Full Text] [Related]
5. Tyr-phosphorylation signals translocate RIN3, the small GTPase Rab5-GEF, to early endocytic vesicles.
Yoshikawa M; Kajiho H; Sakurai K; Minoda T; Nakagawa S; Kontani K; Katada T
Biochem Biophys Res Commun; 2008 Jul; 372(1):168-72. PubMed ID: 18486601
[TBL] [Abstract][Full Text] [Related]
6. SWAP-70 regulates c-kit-induced mast cell activation, cell-cell adhesion, and migration.
Sivalenka RR; Jessberger R
Mol Cell Biol; 2004 Dec; 24(23):10277-88. PubMed ID: 15542837
[TBL] [Abstract][Full Text] [Related]
7. Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit.
Akin C; Brockow K; D'Ambrosio C; Kirshenbaum AS; Ma Y; Longley BJ; Metcalfe DD
Exp Hematol; 2003 Aug; 31(8):686-92. PubMed ID: 12901973
[TBL] [Abstract][Full Text] [Related]
8. c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571.
Vitali R; Cesi V; Nicotra MR; McDowell HP; Donfrancesco A; Mannarino O; Natali PG; Raschellà G; Dominici C
Int J Cancer; 2003 Aug; 106(2):147-52. PubMed ID: 12800187
[TBL] [Abstract][Full Text] [Related]
9. Fps/Fes protein-tyrosine kinase regulates mast cell adhesion and migration downstream of Kit and beta1 integrin receptors.
Smith JA; Samayawardhena LA; Craig AW
Cell Signal; 2010 Mar; 22(3):427-36. PubMed ID: 19892014
[TBL] [Abstract][Full Text] [Related]
10. The stem cell factor-c-kit system and mast cells in human pancreatic cancer.
Esposito I; Kleeff J; Bischoff SC; Fischer L; Collecchi P; Iorio M; Bevilacqua G; Büchler MW; Friess H
Lab Invest; 2002 Nov; 82(11):1481-92. PubMed ID: 12429808
[TBL] [Abstract][Full Text] [Related]
11. Lnk adaptor protein down-regulates specific Kit-induced signaling pathways in primary mast cells.
Simon C; Dondi E; Chaix A; de Sepulveda P; Kubiseski TJ; Varin-Blank N; Velazquez L
Blood; 2008 Nov; 112(10):4039-47. PubMed ID: 18753636
[TBL] [Abstract][Full Text] [Related]
12. The stem cell factor/c-kit receptor pathway enhances proliferation and invasion of pancreatic cancer cells.
Yasuda A; Sawai H; Takahashi H; Ochi N; Matsuo Y; Funahashi H; Sato M; Okada Y; Takeyama H; Manabe T
Mol Cancer; 2006 Oct; 5():46. PubMed ID: 17044945
[TBL] [Abstract][Full Text] [Related]
13. A novel KIT-deficient mouse mast cell model for the examination of human KIT-mediated activation responses.
Smrž D; Bandara G; Zhang S; Mock BA; Beaven MA; Metcalfe DD; Gilfillan AM
J Immunol Methods; 2013 Apr; 390(1-2):52-62. PubMed ID: 23357051
[TBL] [Abstract][Full Text] [Related]
14. KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation.
Lee YN; Brandal S; Noel P; Wentzel E; Mendell JT; McDevitt MA; Kapur R; Carter M; Metcalfe DD; Takemoto CM
Blood; 2011 Mar; 117(13):3629-40. PubMed ID: 21273305
[TBL] [Abstract][Full Text] [Related]
15. Protein-tyrosine phosphatase alpha regulates stem cell factor-dependent c-Kit activation and migration of mast cells.
Samayawardhena LA; Pallen CJ
J Biol Chem; 2008 Oct; 283(43):29175-85. PubMed ID: 18725415
[TBL] [Abstract][Full Text] [Related]
16. Stem cell factor and its receptor c-Kit as targets for inflammatory diseases.
Reber L; Da Silva CA; Frossard N
Eur J Pharmacol; 2006 Mar; 533(1-3):327-40. PubMed ID: 16483568
[TBL] [Abstract][Full Text] [Related]
17. Expression of Stem Cell Factor in Feline Mast Cell Tumour.
Sakurai M; Iwasa R; Sakai Y; Chambers JK; Uchida K; Morimoto M
J Comp Pathol; 2018 Aug; 163():6-9. PubMed ID: 30213375
[TBL] [Abstract][Full Text] [Related]
18. KIT receptor activation by autocrine and paracrine stem cell factor stimulates growth of merkel cell carcinoma in vitro.
Krasagakis K; Fragiadaki I; Metaxari M; Krüger-Krasagakis S; Tzanakakis GN; Stathopoulos EN; Eberle J; Tavernarakis N; Tosca AD
J Cell Physiol; 2011 Apr; 226(4):1099-109. PubMed ID: 20857409
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell c-kit signaling and adaptive immunity: implications for the upper airways.
Oriss TB; Krishnamoorthy N; Ray P; Ray A
Curr Opin Allergy Clin Immunol; 2014 Feb; 14(1):7-12. PubMed ID: 24300419
[TBL] [Abstract][Full Text] [Related]
20. Internalization of Kit together with stem cell factor on human fetal liver-derived mast cells: new protein and RNA synthesis are required for reappearance of Kit.
Shimizu Y; Ashman LK; Du Z; Schwartz LB
J Immunol; 1996 May; 156(9):3443-9. PubMed ID: 8617971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
